Skip to main content
. 2015 Jul 23;15:70. doi: 10.1186/s12894-015-0066-x

Table 2.

Characteristics of patients

Overall (n = 755) Apr./06-Sep./06 (n = 197) Oct./06-Mar./07 (n = 225) Apr./07-Sep./07 (n = 185) Oct./07-Mar./08 (n = 148) p Value
Age (median: yrs) 71 (41–90) 71 (46–94) 72 (41–85) 71 (46–91) 71 (44–90) 0.61a
PSA (median: ng/mL) 7.6 (0.3-5490) 7.6 (0.3–475) 7.6 (0.58–196) 7.2 (0.57–5490) 7.7 (1.0–864) 0.52a
No. of cores (median) 10 (6–12) 10 (6–12) 10 (6–12) 10 (6–12) 10 (6–12) 0.08a
GS 6 (%) 14.6 (n = 110) 17.2 (n = 34) 13.3 (n = 30) 11.9 (n = 22) 16.2 (n = 24) 0.51b
GS 3 + 4 (%) 11.1 (n = 84) 9.1 (n = 18) 12.0 (n = 27) 11.4 (n = 27) 8.1 (n = 12) 0.13b
GS 4 + 3 (%) 8.1 (n = 61) 5.6 (n = 11) 8.9 (n = 20) 7.0 (n = 13) 11.5 (n = 17) 0.23b
GS 8–10 % 6.6 (n = 50) 8.6 (n = 17) 6.2 (n = 14) 5.9 (n = 11) 5.4 (n = 8) 0.64b

PSA Prostate specific antigen, GS Gleason score

aKruskal-wallis test. bchi-square test